Morgan Stanley analyst Keith Weiss maintains Workday (NASDAQ:WDAY) with a Overweight and raises the price target from $310 to $340.
Biodesix Announces Senior Secured Financing Agreement With Perceptive Advisors For Up To $50M
$30 million initial funding
$20 million in future revenue milestone-based funding
Strengthens balance sheet and extends runway with five-year interest only period